Edgworth Eileen, Ernst Lisa, Czigany Zoltan, Saritas Turgay, Zarnitz Laura Sophie, Wiartalla Marc, Boor Peter, Buhl Eva Miriam, Rossaint Rolf, Tolba René H, Doorschodt Benedict, Fabry Gregor, Bleilevens Christian
Department of Anesthesiology, Medical Faculty, University Hospital RWTH Aachen, 52074 Aachen, Germany.
Institute for Laboratory Animal Science and Experimental Surgery, Faculty of Medicine, RWTH Aachen University, 52074 Aachen, Germany.
Antioxidants (Basel). 2022 Jul 6;11(7):1329. doi: 10.3390/antiox11071329.
Normothermic machine perfusion (NMP) of kidneys in combination with an optimized perfusate composition may increase donor organ preservation quality, especially in the case of marginal donor grafts. Optimization of currently employed perfusates is still a subject of present research. Due to the advantages of being cell-free, easy to store, and having minimal antigenicity, hemoglobin-based oxygen carriers, such as HBOC-301 (Oxyglobin, Hemoglobin Oxygen Therapeutics LLC, Souderton, PA, USA), offer an alternative to the commonly used perfusates based on packed red blood cells (pRBC). As previously described, using HBOC results in formation of methemoglobin (metHb) as an adverse effect, inducing hypoxic conditions during the perfusion. As a potential counterpart to metHb formation, the application of the antioxidant ascorbic acid (VitC) is of high interest. Therefore, this study was conducted in four experimental groups, to compare the effect of NMP with (1) HBOC or (3) pRBC, and additionally examine a beneficial effect of VitC in both groups (2) HBOC + VitC and (4) pRBC + VitC. All groups were subjected to NMP for 6 h at a pressure of 75 mmHg. Kidneys in the HBOC groups had a significantly lower renal blood flow and increasing intrarenal resistance, with reduced renal function in comparison to the pRBC groups, as demonstrated by significantly lower creatinine clearance and higher fractional sodium excretion rates. Clinical chemistry markers for tissue damage (LDH, lactate) were higher in the HBOC groups, whereas no significant histological differences were observed. Although the application of VitC decreased oxidative stress levels, it was not able to significantly increase the outcome parameters mentioned above in either group. This study demonstrated that HBOC-301 is inferior to pRBCs in our porcine kidney NMP model, independent of additional VitC administration. Oxidative stress and fragmentation of the hemoglobin polymers could be detected as a possible reason for these results, hence further research, focusing on the use of cell-free oxygen carriers that do not exhibit this complex of issues, is required.
肾脏的常温机器灌注(NMP)与优化的灌注液成分相结合,可能会提高供体器官的保存质量,尤其是在边缘供体移植物的情况下。目前对现有灌注液进行优化仍是当前研究的一个课题。基于血红蛋白的氧载体,如HBOC-301(氧合球蛋白,血红蛋白氧治疗公司,美国宾夕法尼亚州苏德顿),由于具有无细胞、易于储存和抗原性最小等优点,为常用的基于浓缩红细胞(pRBC)的灌注液提供了一种替代方案。如前所述,使用HBOC会导致高铁血红蛋白(metHb)形成,这是一种不良反应,会在灌注过程中引发缺氧状况。作为高铁血红蛋白形成的潜在对应物,抗氧化剂抗坏血酸(维生素C)的应用备受关注。因此,本研究设置了四个实验组,比较NMP与(1)HBOC或(3)pRBC的效果,并额外研究维生素C在两组(2)HBOC + 维生素C和(4)pRBC + 维生素C中的有益作用。所有组均在75 mmHg的压力下进行6小时的NMP。与pRBC组相比,HBOC组的肾脏肾血流量显著降低,肾内阻力增加,肾功能下降,表现为肌酐清除率显著降低和钠排泄分数率升高。HBOC组中组织损伤的临床化学标志物(乳酸脱氢酶、乳酸)较高,而未观察到明显的组织学差异。尽管维生素C的应用降低了氧化应激水平,但它未能显著提高上述两组的结果参数。本研究表明,在我们的猪肾NMP模型中,HBOC-301不如pRBC,与是否额外给予维生素C无关。氧化应激和血红蛋白聚合物的碎片化可能是这些结果的一个原因,因此需要进一步研究,重点关注不出现此类复杂问题的无细胞氧载体的使用。